Noveris Health Sciences is trading at CA$1.17 (-12.03%) as the stock reverses recent speculative buying momentum.

  • The decline follows a volatile week for the stock, which included gains of +21.00% on July 21 and +8.26% on July 22.
  • There are no new company-specific announcements or filings driving the current downward move.
  • The stock is also facing headwinds from a broader biotech sector sell-off and risk-off market rotation.